
Weighing the Good and Bad of Weight-Loss Drugs
60-Second Science sciam.com
This is what was read here when it was published. Scientific American no longer carries it in what it publishes now.
Drugs known as glucagon-like peptide-1 receptor agonists, colloquially called GLP-1 medications, have gone from relatively obscure diabetes treatments to blockbuster weight-loss medications. But is the hype backed up by science? In this episode, freelance science journalist Bethany Brookshire joins host Kendra Pierre-Louis to talk about how these drugs mimic natural hormones, why they’re so effective and what the latest research about their broader health effects says. Plus, we discuss what a recently rolled-out GLP-1 pill, the first of its kind approved for obesity, could mean for the future of weight loss.
Wegovy Weight-Loss Pills Are Now Available in the U.S.—Here’s What That Means“Doctors Are Worried about Prescribing GLP-1s to Certain Patients,” by Bethany Brookshire, in National Geographic. Published online November 20, 2025
More ways to use this
Open on another device
Scan to open this page. Your saved notes and account access are not included.